Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis.
[Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences].
Two cases of chronic immune sensorimotor polyradiculopathy: Expanding the spectrum of chronic immune polyradiculopathies.
The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?
Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis.
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia.
Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
microRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD).
Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical Studies.
MRI utility in the detection of disease activity in clinically stable patients with multiple sclerosis: a retrospective analysis of a community based cohort.
Progressive multifocal leukoencephalopathy.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Patient Management Problem-Preferred Responses.
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.
In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis; presenting a comprehensive picture of pathways and processes affected by multiple sclerosis.
A Qualitative Study of Multiple Health Behaviors in Adults with Multiple Sclerosis.
Effect of Lipopolysaccharide Derived from Pantoea agglomerans on the Phagocytic Activity of Amyloid β by Primary Murine Microglial Cells.
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja].
LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.
Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis.
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.
Extraction, Analytical and Advanced Methods for Detection of Allura Red AC (E129) in Food and Beverages Products.
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Pages
« first
‹ previous
…
703
704
705
706
707
708
709
710
711
…
next ›
last »